Skip to main content
Research and analysis

Outbreaks under monitoring: week 45 (week ending 8 November 2026)

Updated 19 November 2026

The following signal relates to an ongoing outbreak, with data as of 9 November 2026

Disease or pathogen Bundibugyo virus disease (BVD)
Location Multi-country
Status Update
Reporting date 15 May to 9 November 2026
Summary On 15 May 2026, an outbreak of Ebola disease caused by Bundibugyo virus was declared in the Democratic Republic of the Congo (DRC) and Uganda. On 17 May 2026, the WHO Director-General determined that the outbreak constitutes a public health emergency of international concern. The outbreak in DRC remains a public health emergency of international concern as of the latest WHO Emergency Committee meeting (Facebook: logi required), held on 18 August 2026.

As of 9 November 2026 (in French), 11,042 confirmed cases and 5,387 confirmed deaths have been reported in the DRC. This is an increase of 510 confirmed cases and 261 deaths since the last Outbreaks Under Monitoring report. Cases have been reported in 67 health zones across 8 provinces (Ituri, North Kivu, South Kivu, South-Ubangi, North-Ubangi, Haut-Uele, Bas-Uele and Tshopo). Since the beginning of the outbreak, the highest number of cases have been reported in Ituri (7,684 cases, 3,628 deaths) and North Kivu (2,737 cases, 1,505 deaths) provinces. As of 7 November 2026, the 7-day average of newly reported cases in North Kivu province (31 cases) has surpassed Ituri province (29 cases). Overall, a high and sustained level of transmission continues to be observed in the DRC, with the recent national 7-day average reported to be 65 to 67 new cases per day. This outbreak has become the largest recorded BVD outbreak and is the second largest Ebola disease outbreak to date.

On 6 October 2026 (Facebook: login required), Kenya’s Ministry of Health reported the first confirmed case of BVD in Kenya, imported from the DRC. The case travelled from the DRC to Kampala, Uganda, by road and arrived in Nairobi via a flight on 3 October 2026. Samples from the case tested positive for Ebola Bundibugyo virus. The case was given supportive treatment but died on 5 October 2026. No new cases have been reported in Kenya since 19 October 2026, with the total remaining at 9 confirmed cases including 2 deaths (Facebook: login required). The second fatal case (X) was reported to be a close family member of the index case. All secondary cases are epidemiologically linked to the initial imported case, and all were identified while in quarantine. According to Kenya’s MoH there is no evidence of transmission outside of this cluster.

On 20 October 2026, Nigeria’s Centre for Disease Control (Facebook: login required) reported the first confirmed case of BVD. The case was confirmed in Abuja, in a woman who had recently travelled from Uganda, with transit through Addis Ababa, Ethiopia. The case was later medically evacuated to Switzerland for further treatment. As of 8 November 2026, no additional cases have been reported.

On 27 August 2026, WHO and the Africa Centres for Disease Control and Prevention declared the end of the outbreak in Uganda following no new cases since the last case was discharged from care on 16 July 2026. A total of 20 confirmed cases (including 2 deaths) were reported in Uganda. Of the confirmed cases, 15 were imported from the DRC and 5 were secondary cases among contacts.

This is the 17th recorded Ebola disease outbreak in the DRC since the virus was first identified in 1976. Bundibugyo virus was first identified in 2007 in Bundibugyo district, western Uganda. A second outbreak caused by Bundibugyo virus was reported in the DRC in 2012.

WHO continues to assess the risk of this event as very high in the DRC, high for countries with land borders adjoining the DRC, and low for the remaining countries in the African region, and globally.

Previous experience from the 2014–2016 West Africa outbreak suggests a limited importation risk. Imported EBOD cases are extremely rare in the UK. Since 1976, there have been 5 confirmed cases of EBOD reported in the UK. One was a laboratory-acquired case in 1976, 3 cases were in healthcare workers associated with the West African epidemic in 2014 to 2015, and one individual was medically evacuated to the UK from the DRC during the 2026 Bundibugyo virus outbreak. The risk of the current outbreak to the UK population is assessed as low.
Further information Ebola: overview, history, origins and transmission
Ebola virus disease: clinical management and guidance
Ebola and Marburg haemorrhagic fevers: outbreaks and case locations
UKHSA blog: What is Ebola and how does it spread?
NaTHNaC country information page: Democratic Republic of the Congo, Uganda, and Kenya.

Epidemiological week 45, 2 to 8 November 2026

Disease or pathogen Avian influenza A(H9N2)
Location China
Status Update
Reporting date 29 October 2026
Summary Between 23 to 29 October 2026, 2 human cases of avian influenza A(H9N2) were reported from China among children. The first case, from Liaoning province, experienced symptom onset on 20 September 2026. The second case, from Guangxi Zhuang Autonomous Region, experienced symptom onset on 13 October 2026. Both cases were exposed to poultry and have since fully recovered. Close contacts for both cases have tested negative for influenza A.

Between 9 January and 29 October 2026, 37 human cases of avian influenza A(H9N2) have been reported from China. In comparison, 29 cases were reported in China throughout all of 2025, an increase from 11 cases in 2024. Most human cases of avian influenza A(H9N2) have been associated with exposure to infected poultry or contaminated environments and have resulted in mild symptoms. Current evidence shows that avian influenza A(H9N2) viruses have not acquired the ability for sustained human-to-human transmission, according to WHO.
Further information Avian influenza: guidance, data and analysis
NaTHNaC country information page: China
Disease or pathogen Crimean-Congo haemorrhagic fever (CCHF)
Location Mauritania
Status Update
Reporting date 25 October 2026
Summary During the week ending 25 October 2026, one confirmed fatal case of CCHF was reported in the Assaba region, Mauritania. A total of 3 confirmed cases, including 2 deaths have been reported in Mauritania in 2026. Of these, 2 cases and one death have been reported in the Traza region. Cases of CCHF have been reported in Mauritania previously, with the last confirmed human case detected in 2023.

CCHF is not present in the UK, nor are there any identified established populations of Hyalomma ticks, the principal vectors of CCHF virus. Confirmed CCHF cases have been imported into the UK, including one fatal case in 2012 and one in 2014.
Further information Crimean-Congo haemorrhagic fever: origins, reservoirs, transmission and guidelines
HAIRS risk assessment: Crimean-Congo haemorrhagic fever
NaTHNaC country information page: Mauritania
Disease or pathogen Chikungunya
Location Switzerland
Status New
Reporting date 4 November 2026
Summary On 4 November, Switzerland’s Federal Office of Public Health reported the first ever locally acquired cases of chikungunya in Switzerland. According to media (in German), 4 cases were detected in Ticino.

The mosquito vector for chikungunya, Aedes albopictus, has previously been reported in Ticino, in 2003. In addition, between January and August 2026, 55 travel associated cases of chikungunya were reported in Switzerland. Under appropriate conditions, local transmission of chikungunya can occur if an infected individual returns from abroad and is bitten by an Aedes albopictus mosquito which can continue to transmit the virus to other individuals. In response, health authorities in Ticino have assessed the situation as low risk (in German).

In the UK, an increase in travel-associated chikungunya cases was reported in 2025. Most cases reported travel to Sri Lanka, India and Mauritius. No locally acquired cases of chikungunya have ever been reported in the UK.
Further information Chikungunya: transmission, epidemiology and guidance  
Chikungunya: epidemiology in England, Wales and Northern Ireland 
HAIRS risk assessment: Chikungunya virus
NaTHNaC country information page: Switzerland